Carrie Mulherin

Immunicon Corp. develops, manufactures, markets and sells proprietary cell-based diagnostic and research products and services. It provides services to pharmaceutical and biotechnology companies to develop new therapeutic agents, which focuses on cancer disease management. Immunicon's products and technology platforms have application in cancer research and in other fields of medicine, such as cardiovascular and infectious disease. The company was founded in 1983 and is headquartered in Huntingdon Valley, PA.

BioBehavioral Diagnostics Co. manufactures and markets attention-deficit hyperactivity disorder systems. It develops and markets a proprietary platform technology to objectively measure specific behaviors that correlate with brain function and deficits in inhibitory control. The firm's product Quotient ADHD System measures impulsivity, hyperactivity and inattention as an aid in the assessment of ADHD and this system includes a data acquisition unit, a proprietary normative database, analytics and reports. The company was founded by Eric B. Gordon in 2006 and is headquartered in Westford, MA.

Brava Diagnostics, Inc.develops acute care diagnostic products. It specializes in IVD, point-of-care, cardiovascular, sepsis, and acute care services. The company was founded by Byron Hewett, David Okrongly and Carrie Mulherin in August 2018 and is headquartered in Boulder, CO.